TOR1AIP2
Basic information
Region (hg38): 1:179839967-179877803
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Muscular dystrophy, limb-girdle, type 2Y | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Cardiovascular; Musculoskeletal | 24856141 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TOR1AIP2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001199260.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 3 | |||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 2 | 1 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TOR1AIP2 | protein_coding | protein_coding | ENST00000367612 | 4 | 37837 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 3.25e-9 | 0.176 | 125732 | 0 | 16 | 125748 | 0.0000636 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.801 | 210 | 245 | 0.856 | 0.0000118 | 3105 |
| Missense in Polyphen | 58 | 89.384 | 0.64888 | 1176 | ||
| Synonymous | -0.174 | 100 | 97.8 | 1.02 | 0.00000507 | 923 |
| Loss of Function | 0.390 | 14 | 15.7 | 0.894 | 7.48e-7 | 195 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000381 | 0.000272 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.0000798 | 0.0000791 |
| Middle Eastern | 0.000381 | 0.000272 |
| South Asian | 0.0000371 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for endoplasmic reticulum integrity. Regulates the distribution of TOR1A between the endoplasmic reticulum and the nuclear envelope as well as induces TOR1A, TOR1B and TOR3A ATPase activity. {ECO:0000269|PubMed:19339278, ECO:0000269|PubMed:23569223, ECO:0000269|PubMed:24275647}.;
Recessive Scores
- pRec
- 0.0771
Intolerance Scores
- loftool
- 0.577
- rvis_EVS
- -0.31
- rvis_percentile_EVS
- 32.06
Haploinsufficiency Scores
- pHI
- 0.0764
- hipred
- N
- hipred_score
- 0.327
- ghis
- 0.452
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.223
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tor1aip2
- Phenotype
Gene ontology
- Biological process
- endoplasmic reticulum organization;positive regulation of ATPase activity;protein localization to nuclear envelope
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;nuclear membrane
- Molecular function
- ATPase activator activity;ATPase binding